Thus, to broaden the scope of atypical activities of chemokine receptors in cancer, a section of the review is dedicated to atypical roles of additional members of the ACKRs sub-group in malignancy: ACKR1, ACKR2, and ACKR4. This evidence concerns the gene ACKR4 and cancer.